Security key
10501E201
BRAINSTORM CELL THERAPEUTICS - COM NEW (BCLI)
CUSIP: 10501E201
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 8,396,793
- Total 13F value
- $32,140,271
- Share change
- +85,499
- Put/Call ratio
- 133%
- SEC-reported price per share
- $3.83
- Number of holders
- 69
- Value change
- -$25,813
- Number of buys
- 33
- Number of sells
- 44
Open additional details 1 more signal available
Report period
Q1 2021
Institutions
69
Top holders
10
BCLI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2021
Previous quarter: Q4 2020
BRAINSTORM CELL THERAPEUTICS INC. SEC filings
BRAINSTORM CELL THERAPEUTICS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 10501E201
Recent filing periods:
Ownership snapshot
Top reported holders of BCLI - BRAINSTORM CELL THERAPEUTICS - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F
Highest disclosed value: $8,690,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. has the largest disclosed position value at $8.69M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value
Top 5
BlackRock Finance, Inc.
$8.69M
VANGUARD GROUP INC
$5.86M
STATE STREET CORP
$2.15M
GEODE CAPITAL MANAGEMENT, LLC
$1.84M
JPMORGAN CHASE & CO
$1.78M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$8,690,000
1,920,340 shares
|
— | 31 Dec 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$5,860,000
1,295,088 shares
|
— | 31 Dec 2020 |
| STATE STREET CORP |
13F
Company
|
—
class O/S missing
|
$2,148,000
474,691 shares
|
— | 31 Dec 2020 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$1,836,000
405,923 shares
|
— | 31 Dec 2020 |
| JPMORGAN CHASE & CO |
13F
Company
|
—
class O/S missing
|
$1,776,000
392,417 shares
|
— | 31 Dec 2020 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
class O/S missing
|
$1,677,000
370,649 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
69
Shares
8,396,793
Rows available
69
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
84
Q1 2021 holders
69
Holder diff
-15
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend